Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy

Bibliographic Details
Main Authors: Luis Enrique Munoz, Richa Sharma, Ramireddy Bommireddy, Lenore Monterroza, Rohini N. Guin, Sarah G. Samaranayake, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Mala Shanmugam, Periasamy Selvaraj
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/11/e002614.full
_version_ 1818733092176658432
author Luis Enrique Munoz
Richa Sharma
Ramireddy Bommireddy
Lenore Monterroza
Rohini N. Guin
Sarah G. Samaranayake
Christopher D. Pack
Sampath Ramachandiran
Shaker J.C. Reddy
Mala Shanmugam
Periasamy Selvaraj
author_facet Luis Enrique Munoz
Richa Sharma
Ramireddy Bommireddy
Lenore Monterroza
Rohini N. Guin
Sarah G. Samaranayake
Christopher D. Pack
Sampath Ramachandiran
Shaker J.C. Reddy
Mala Shanmugam
Periasamy Selvaraj
author_sort Luis Enrique Munoz
collection DOAJ
first_indexed 2024-12-17T23:43:58Z
format Article
id doaj.art-084f712d463c43b8b36ee6e0f2e59676
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-17T23:43:58Z
publishDate 2021-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-084f712d463c43b8b36ee6e0f2e596762022-12-21T21:28:21ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-0191110.1136/jitc-2021-002614Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapyLuis Enrique Munoz0Richa Sharma1Ramireddy Bommireddy2Lenore Monterroza3Rohini N. Guin4Sarah G. Samaranayake5Christopher D. Pack6Sampath Ramachandiran7Shaker J.C. Reddy8Mala Shanmugam9Periasamy Selvaraj101 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA2 Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA1 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA1 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA1 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA1 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA3 Metaclipse Therapeutics Corporation, Atlanta, Georgia, USA3 Metaclipse Therapeutics Corporation, Atlanta, Georgia, USA3 Metaclipse Therapeutics Corporation, Atlanta, Georgia, USA2 Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA1 Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USAhttps://jitc.bmj.com/content/9/11/e002614.full
spellingShingle Luis Enrique Munoz
Richa Sharma
Ramireddy Bommireddy
Lenore Monterroza
Rohini N. Guin
Sarah G. Samaranayake
Christopher D. Pack
Sampath Ramachandiran
Shaker J.C. Reddy
Mala Shanmugam
Periasamy Selvaraj
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
Journal for ImmunoTherapy of Cancer
title Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
title_full Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
title_fullStr Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
title_full_unstemmed Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
title_short Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
title_sort metformin reduces pd l1 on tumor cells and enhances the anti tumor immune response generated by vaccine immunotherapy
url https://jitc.bmj.com/content/9/11/e002614.full
work_keys_str_mv AT luisenriquemunoz metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT richasharma metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT ramireddybommireddy metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT lenoremonterroza metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT rohininguin metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT sarahgsamaranayake metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT christopherdpack metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT sampathramachandiran metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT shakerjcreddy metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT malashanmugam metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy
AT periasamyselvaraj metforminreducespdl1ontumorcellsandenhancestheantitumorimmuneresponsegeneratedbyvaccineimmunotherapy